Rubinstein-Taybi syndrome and psychiatric disorders

Journal of Intellectual Disability Research

Volumn 42, Issue 4, 1998, Pages 284-292

  Levitas, A S ^a   Reid, C S ^b  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b BEAVER COLLEGE   (United States)

Author keywords

Bipolar disorder; Gene mapping; Multiple congenital anomaly syndromes; Obsessive compulsive disorder; Regulatory genes

Indexed keywords

NEUROLEPTIC AGENT; NEUROTRANSMITTER;

ARTICLE; CHROMOSOME 16P; CLINICAL ARTICLE; DOPAMINERGIC SYSTEM; GENE LOCUS; HUMAN; MENTAL DISEASE; MOOD; MOTOR DYSFUNCTION; NEUROLEPTIC MALIGNANT SYNDROME; OBSESSION; PHENOTYPE; PREVALENCE; RISK; RUBINSTEIN SYNDROME; SEROTONINERGIC SYSTEM; TIC;

ADULT; COMORBIDITY; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MENTAL RETARDATION; MIDDLE AGED; PHENOTYPE; PSYCHIATRIC STATUS RATING SCALES; RUBINSTEIN-TAYBI SYNDROME;

EID: 0031670113     PISSN: 09642633     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2788.1998.00136.x     Document Type: Article

References (33)

1. Arias J., Alberts A. S., Brindle P., Claret F. X., Smeal T., Karin M., Feramisco J. & Montminy M. (1994) Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370, 226-9.
2. Berry-Kravis E. & Muttenlocker P. R. (1992) Cyclic AMP metabolism in fragile-X syndrome. Annals of Neurology 31, 22-6.
3. Berry-Kravis E. & Sklena P. (1993) Demonstration of abnormal cyclic AMP production in platelets from patients with fragile-X syndrome. American Journal of Medical Genetics 45, 81-7.
4. Breuning M. H., Dauwerse H. G., Fugazza G., et al. (1993) Rubinstein-Taybi syndrome caused by a submicroscopic deletion within 16p13.3. American Journal of Human Genetics 52, 249-54.
5. Chen X. N. & Kornberg J. R. (1995) Localization of human CREBBP (CREB binding protein) to 16p13.3 by fluorescent in situ hybridization. Cytogenetics and Cell Genetics 71, 56-7.
6. Hennekam R. C. M., Baselier A. C. A., Beyaert E., et al. (1992) Psychological and speech studies in Rubinstein-Taybi syndrome. American Journal on Mental Retardation 96, 645-60.
7. Hennekam R. C. M., Van Den Boogaard M. J. & Van Doorne J. M. (1991) A cephalometric study in Rubinstein-Taybi syndrome. Journal of Craniofacial Genetics and Developmental Biology 20, 33-40.
8. King M. H., Dengin C., McCracken J. M., et al. (1994) Psychiatric consultation in severe and profound mental retardation. American Journal of Psychiatry 151, 1802-8.
9. Kwok R. P. S., Lundblad J. R., Chrivia J. C., Richards J. P., Bachinger H. P., Brennan R. G., Roberts S. G. E., Green M. R. & Goodman R. H. (1994) Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370, 223-6.
10. Lacombe D., Sabra R., Taint L. & Batten J. (1992) Confirmation of assignment of a locus for Rubinstein-Taybi syndrome gene to 16p13.3. American Journal of Medical Genetics 44, 126-8.
11. Levitas A. (1996) Neuropsychiatric aspects of fragile X syndrome. Seminars in Neuropsychiatry 1, 154-67.
12. Levitas A. S. & Gilson S. F. (1990) Toward the developmental understanding of the impact of mental retardation on assessment of psychopathology. In: Assessment of Behavior Problems in Persons with Mental Retardation Living in the Community (eds E. Dibble & D. G. Gray), pp. 71-106. National Institute of Mental Health, Rockville, MD.
13. Levitas A. S. & Gilson S. F. (1994) Psychosocial development of children and adolescents with mild and moderate mental retardation. In: Mental Health in Mental Retardation: Recent Advances and Practices (ed. N. Bouras), pp. 34-45. Cambridge University Press, Cambridge.
14. McGaughran J. M., Gaunt L., Doer J., et al. (1996) Rubinstein-Taybi syndrome with deletions of FISH probe RT1 at 16p13.3 in two UK patients. Journal of Medical Genetics 33, 82-3.
15. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L. & Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proceedings of the National Academy of Sciences, USA 82, 424-59.
16. Masuno M., Omasum K., Carissa W., et al. (1994) Submicroscopic deletion of chromosome region 16p13.3 in a Japanese patient with Rubinstein-Taybi syndrome. American Journal of Medical Genetics 53, 352-4.
17. Nordheim A. (1994) CREB takes CBP to tango. Nature 370, 177-8.
18. Papolos D. F., Faedda G. L., Veit S., et al. (1996) Bipolar spectrum disorders in patients diagnosed with Velo-Cardio-Facial syndrome: Does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? American Journal of Psychiatry 153, 1541-7.
19. Ram A., Guedj F., Cravchik A., et al. (1997) No abnormality in the gene for the G protein stimulatory a-subunit in patients with bipolar disorder. Archives of General Psychiatry 54, 44-8.
20. Reid A. H. (1972a) Psychoses in adult mental defectives. I: Schizophrenic and paranoid psychoses. British Journal of Psychiatry 120, 213-18.
21. Reid A. H. (1972b) Psychoses in adult mental defectives. II: Manic-depressive psychosis. British Journal of Psychiatry 120, 205-12.
22. Rubinstein J. H. (1990) Broad thumb-hallux (Rubinstein-Taybi) syndrome 195788. American Journal of Medical Genetics Suppl. 6, 3-16.
23. Rubinstein J. H. & Taybi H. (1963) Broad thumbs and toes and facial abnormalities: a possible mental retardation syndrome. American Journal of Diseases of Children 105, 588-608.
24. Shelton R. C., Manier H. & Sulser F. (1996) cAMP-dependent protein kinase activity in major depression. American Journal of Psychiatry 153, 1037-42.
25. Siomi H., Siomi M. C. & Nussbaum R. (1993) The protein product of the fragile-X gene FMR-I has characteristics of an RNA binding protein. Cell 74, 291-8.
26. Smyth M. H., Kali G., Brynjolfsson J., et al. (1996) Further tests for linkage of bipolar affective disorder to the tyrosine hydroxylase gene locus on chromosome 11p15 in a new series of multiplex British affective disorder pedigrees. American Journal of Psychiatry 153, 271-4.
27. Sovner R. (1986) Limiting factors in the use of DSM-III criteria with mentally ill/mentally retarded persons. Psychopharmacology Bulletin 22, 1055-9.
28. Stevens C. A., Carey J. C. & Blackburn L. (1990) Rubinstein-Taybi syndrome: a natural history study. American Journal of Medical Genetics Suppl. 6, 30-7.
29. Stirt J. A. (1981) Anesthetic problems in Rubinstein-Taybi syndrome. Anesthesia and Analgesia (Cleveland) 60, 534-6.
30. Stirt J. A. (1982) Succinylcholine in Rubinstein-Taybi syndrome. Anesthesiology 57, 429.
31. Szymanski L. S. (1988) Integrative approach to diagnosis of mental disorders in retarded persons. In: Mental Retardation and Mental Health: Classification, Diagnosis, Treatment and Services (eds A. J. Stark, F. J. Menolascino, M. H. Albarelli & V. C. Gray). Springer-Verlag, Berlin.
32. Wallerstein R., Anderson C. E., Hay B., et al. (1997) Submicroscopic deletions at 16p13.3 in Rubinstein-Taybi syndrome: frequency and clinical manifestations in a North American population. Journal of Medical Genetics 34, 203-6.
33. Wright E. C. (1982) The presentation of mental illness in mentally retarded adults. British Journal of Psychiatry 141, 496-502.